Patients with moderate to severe and severe alopecia areata have a greater burden of comorbid atopic dermatitis than those with mild alopecia areata.

Medical use of prescription stimulants for ADHD increased between 2005 and 2023, but nonmedical use decreased over that time.

Some of the notable drug approvals that occurred in July 2025.

Black patients with acral lentiginous melanoma are at a higher risk of mortality than White patients, independent of known risk factors.

Patients with EM or CTD-related CryoVas often experience relapse following RTX and corticosteroid-induced remission.

Gestational carriers have elevated rates of mental illness compared with those carriers who conceived unassisted or by IVF.

Among severely impaired and terminally ill nursing home residents, about one-third of all-cause hospitalizations were potentially avoidable.

The Trump administration will end VA abortions for service members and beneficiaries in cases of rape, incest or to save the mother’s life.

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

A significant burden of neuropsychiatric comorbidities exists among patients with PPD and various psychophysiological disorders.

Trump's new EHR system will let people upload medical records and use QR codes to share details with health care providers.

Guselkumab was an effective treatment for plaque psoriasis with extensive body involvement among patients with skin of color.